Attention to circadian rhythm abnormalities in managing blood pressure of patients with chronic kidney disease

doi:10.3877/cma.j.issn.2095-3216.2014.02.002

Abstract

Abstract:

The circadian rhythm abnormalities of blood pressure are potent predictors of cardiovascular and cerebrovascular events in patients with hypertension. In patients with chronic kidney disease (CKD), regardless of whether their blood pressure levels are normal or not, the abnormal circadian rhythm of blood pressure is very common, and is an independent risk factor for CKD progression and cardiovascular complications, Therefore, during the management of bood pressure in patients with CKD, in addition to standard control of blood pressure levels, more attention should be paid to the monitoring,evaluation, and active intervention of nocturnal blood pressure and the circadian rhythm of blood pressure.The main measures include 24-hour ambulatory blood pressure monitoring, lifestyle changes, salt restriction,joint use of antihypertensive medication,and medicine-taking at bedtime.

Key words: Circadian blood pressure rhythm, Chronic kidney disease

Yani He, Lirong Lin. Attention to circadian rhythm abnormalities in managing blood pressure of patients with chronic kidney disease[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2014, 03(02): 65-67.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2014.02.002

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2014/V03/I02/65

References 27

1	Hermida RC, Ayala DE, Mojón A, Fernández JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level-the “normotensive nondipper” paradox [J]. Chronobiol Int,2013,30(1-2):87-98.
2	Soylu A, Yazici M, Duzenli MA, et al. Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives [J]. Circ J,2009,73(5):899-904.
3	Mojón A,Ayala DE,Piñeiro L,et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease [J]. Chronobiol Int,2013,30(1-2):145-158.
4	Mancia G, Fagard R, Narkiewicz K, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology(ESC): ESH/ESC task force for the management of arterial hypertension [J]. J Hypertens,2013,31(10):1925-1938.
5	Hermida RC, Smolensky MH, Ayala DE, et al. Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy [J].Nephrol Dial Transplant,2013, Sep 5. [Epub ahead of print].
6	Iimuro S, Imai E, Watanabe T, et al. Clinical correlates of ambulatory BP monitoring among patients with CKD [J]. Clin J Am Soc Nephrol,2013,8(5):1-10.
7	Davidson MB,Hix JK,Vidt DG,Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate [J]. Arch Intern Med,2006,166(8):846-852.
8	Redon J, Plancha E, Swift PA, et al. Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4 [J]. J Hypertens,2010,28(3):602-607.
9	Lin L,He Y. Contributing factors for circadian rhythm variation of blood pressure in adult IgAN patients[J]. J Am Soc Nephrol,2013,24:421A.
10	Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes[J].N Engl J Med,2002,347(11):797-805.
11	Goswami P, Drawz P, Rahman M. Nocturnal dosing and chronic kidney disease progression: new insights [J]. Curr Opin Nephrol Hypertens,2009,18(5):381-385.
12	Tsioufis C, Andrikou I, Thomopoulos C, et al. Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomes [J]. Am J Nephrol,2011,33(3):277-288.
13	Cohen DL, Huan Y, Townsend RR. Townsend. Ambulatory Blood Pressure in Chronic Kidney Disease[J]. Curr Hypertens Rep,2013,15(3):160-166.
14	de la Sierra A, Gorostidi M, Banegas JR, et al. Nocturnal hypertension or nondipping: which Is better associated with the cardiovascular risk profile [J]? Am J Hypertens, 2013 Sep 23.[Epub ahead of print].
15	Amar J,Vernier I, Rossignol E,et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients [J]. Kidney Int,2000,57(6):2485-2491.
16	Liu M, Takahashi H, Moriua Y, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients [J]. Nephrol Dial Transplant,2003,18(3):563-569.
17	Wang C,Zhang J,Liu X,et al. Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease [J]. PLoS One,2013,8(2):e55419.
18	Tonbul Z, Altintepe L, Sözlü C, et al. Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis(CAPD) patients [J]. J Hum Hypertens,2002,16(8):585-589.
19	Kanbay M, Turgut F, Uyar ME, et al. Causes and mechanisms of nondipping hypertension [J]. Clin Exp Hypertens, 2008, 30(7):585-597.
20	Firsov D, Bonny O. Olivier Bonny. Circadian regulation of renal function [J]. Kidney Int,2010,78(7):640-645.
21	Bonny O, Firsov D. Circadian regulation of renal function and potential role in hypertension [J]. Curr Opin Nephrol Hypertens,2013,22(4):439-444.
22	Mahabala C, Kamath P, Bhaskaran U, et al. Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently [J]? Vasc Health Risk Manag,2013,9:125-133.
23	Hermida RC, Ayala DE, Mojón A, et al. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD[J]. J Am Soc Nephrol,2011,22(12):2313-2321.
24	Yanagi M, Tamura K, Fujikawa T, et al. The angiotensin Ⅱtype 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease [ J].Hypertens Res,2013,36(3):262-269.
25	Minutolo R, Gabbai FB, Borrelli S, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD:an 8-week uncontrolled trial [J]. Am J Kidney Dis,2007,50(6):908-917.
26	Hermida RC, Ayala DE, Smolensky MH, et al. Chronotherapy improves blood pressure control and reduces vascular risk in CKD[J]. Nat Rev Nephrol,2013,9(6):358-368.
27	Crespo JJ,Piñeiro L,Otero A,et al. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease [J]. Chronobiol Int,2013,30(1-2):159-175.

[1]	Xiaoqing Tang, Ping He, You Yang, Xia Luo, Juying Zhang, Xin Yang, Jinhong Yu. Correlation of sound touch elastography combined with pulsed wave Doppler ultrasound imaging parameters with stage of early chronic kidney disease and their clinical significance [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(05): 491-499.
[2]	Shuxun Ling, Yue Tu, Siyi Liu. Visualization analysis on knowledge map of mesenchymal stem cells in the research field of chronic kidney disease [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(02): 73-82.
[3]	Branch of Organ Transplant of Chinese Medical Association, Branch of Organ Transplant Physicians of Chinese Medical Doctor Association. Clinical practice guidelines for kidney injury management of liver transplant recipients in China(2023 edition) [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(03): 276-288.
[4]	Bokai Cheng, Guang Yang. Progress of research on application of hyperinsulinemic-euglycemic clamp technique for assessing insulin resistance in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 334-339.
[5]	Rongrong Feng, Xiaole Su, Lihua Wang. Research progress on biological markers related to complication of cardiovascular disease in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(05): 273-278.
[6]	Junnan Guo, Hui Lin, Yilin Ren, Xi Qiao. Progress of research on the role of amino acid metabolism disturbance in the transition from AKI to CKD [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(05): 283-287.
[7]	Xiaolong Wang, Jie Wu, Shuwei Duan, Chaohui Wang, Na Pan, Yuanyuan Bai, Hangtian Li, Guangyan Cai. Effect of different levels of physical activity on the prognosis of patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(03): 121-128.
[8]	Yinan Zhang, Guozhen Zhu. Research progress on the transition from acute kidney injury to chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(02): 106-112.
[9]	Yansheng Wu, Xianwen Zhang, Lin Wang. Research progress on the relationship between intestinal microecology and immunity in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(02): 101-105.
[10]	Jinyi Zhang, Yuehong Li. Research progress on the efficacy and strategy of SARS-CoV-2 vaccination in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(02): 97-100.
[11]	Wuhao Xiao, Kanghan Liu. Research progress on the treatment of osteoporosis in patients with advanced chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(02): 92-96.
[12]	Peipei Xi, Jiajun Zhou. Progress in research of sarcopenia in patients with chronic kidney disease: pathogenesis, diagnosis, and treatment [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 491-495.
[13]	Meiju Wei, Ling Pan. Role of gut microbiota-bile acid metabolism axis in chronic kidney disease [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(02): 219-222.
[14]	Caijun Yuan, Ping Wen, Lingling Xu. Advancements in application of continuous glucose monitoring in patients with chronic kidney disease and diabetes [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(01): 79-82.
[15]	Ting Luo, Lingzhi Qiu, Dong Yi, Hua Yan. Research progress on the relationship between mitochondrial dysfunction and cardiovascular disease, ischemic stroke and chronic kidney disease [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2024, 18(01): 60-63.

Please choose a citation manager

Content to export